GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Artelo Biosciences
Artelo Biosciences is a biotech company developing cannabinoid-based drugs. Its stock price is a bet on the medical potential of these compounds. The chart reflects the risks and opportunities associated with clinical trials and the regulatory environment.
Share prices of companies in the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. We classified it as a "Narco-Pharma" company because it uses cannabis derivatives. The chart below shows the dynamics of this risky biotech sector.
Broad Market Index - GURU.Markets
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. Its scientific approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Artelo compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
ARTL - Daily change in the company's share price Artelo Biosciences
For Artelo Biosciences, Inc., a company developing cannabinoid-based drugs, daily volatility reflects sensitivity to clinical trial data. This metric is an important element in assessing risks in this innovative field.
Daily change in the price of a set of shares in a market segment - Narco farm
Artelo Biosciences is developing cannabinoid-based drugs for the treatment of cancer and other diseases. This is a highly speculative and regulated sector. The chart below illustrates the high volatility typical of cannabis biotech, providing context for assessing ARTL's risks.
Daily change in the price of a broad market stock, index - GURU.Markets
Artelo Biosciences develops cannabinoid-based drugs. The company operates at the intersection of two volatile sectors: biotech and cannabis. Its shares react to scientific and regulatory news, adding unique dynamism and unpredictability to the market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Artelo Biosciences
For Artelo Biosciences, the year-to-date performance is a story of cannabinoid-based drug development. Its 12-month market cap is entirely dependent on clinical trial data. The success of its lead candidate, which is being studied for anorexia, could be a breakthrough and confirmation of the therapeutic potential of this complex molecule.
Annual dynamics of market capitalization of the market segment - Narco farm
Artelo, a biotech company developing cannabinoid-based drugs, is completely independent of the sector and depends on news about clinical trials and legalization. Its stock price will reflect investors' speculative belief in the potential of this innovative approach.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Artelo Biosciences, a company exploring the potential of the cannabinoid system for the development of new drugs, sits at the intersection of pharmacology and cannabis legalization. Its year-over-year market capitalization dynamics demonstrate how scientific discoveries and legislative changes are impacting the investment appeal of this controversial yet promising sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Artelo Biosciences
Artelo is a biopharmaceutical company developing cannabinoid-based drugs. Its monthly performance is entirely dependent on progress in its clinical trials. News about research results and regulatory changes are the main drivers.
Monthly dynamics of market capitalization of the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer, pain, and other diseases. Its future depends on clinical data and the regulatory environment. The landscape of the cannabinoid biotech sector reflects both scientific interest and the legal barriers that affect companies like Artelo.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Artelo Biosciences is a biotech company working with the cannabinoid system to create new drugs. Its stock moves at the intersection of two trends: biotech and cannabis. Its performance depends on research results and regulatory changes, making it independent of the broader market, but highly volatile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Artelo Biosciences
Artelo Biosciences, a biotech company working with the cannabinoid system to create new drugs, sits at the intersection of pharmaceuticals and the cannabis industry. Its weekly stock price reflects both progress in clinical trials and changes in cannabis legislation.
Weekly dynamics of market capitalization of the market segment - Narco farm
Artelo Biosciences is developing cannabinoid-based drugs for the treatment of cancer and other diseases. Its stock is heavily dependent on changes in cannabis legislation and the results of clinical trials. The chart will reveal how unique its path is compared to the traditional pharmaceutical industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Artelo Biosciences is developing cannabinoid-based drugs. Its shares are driven by news of legalization and trial results. The chart will show how disconnected its performance is from the broader market and how it operates according to the industry's own, highly volatile laws.
Market capitalization of the company, segment and market as a whole
ARTL - Market capitalization of the company Artelo Biosciences
Artelo Biosciences' market capitalization chart reflects investors' assessment of its developments in cannabinoid therapeutics. Its dynamics reflect the market's belief that its drugs can treat rare diseases and cancer. Its high volatility is a direct response to clinical trial data and changes in the regulatory environment for cannabinoids.
ARTL - Share of the company's market capitalization Artelo Biosciences within the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs. Its market share is small, but it takes a scientific approach to this class of compounds. Its market capitalization is based on its research portfolio for the treatment of oncology and other diseases.
Market capitalization of the market segment - Narco farm
This chart shows the total market capitalization of the entire legal cannabis and pharmaceutical sectors. For Artelo Biosciences, which uses cannabinoids to develop drugs, this line is a map of the legalization of science. Its dynamics reflect how once-illegal substances are becoming the basis for the creation of new, potentially breakthrough therapeutics.
Market capitalization of all companies included in a broad market index - GURU.Markets
Artelo Biosciences develops cannabinoid-based drugs. Its market capitalization reflects the medical potential of cannabis. This represents the market share of the scientific research and legalization of one of the most well-known plants.
Book value capitalization of the company, segment and market as a whole
ARTL - Book value capitalization of the company Artelo Biosciences
Artelo Biosciences is a pharmaceutical company developing cannabinoid-based drugs. Its book value is its financial resources for R&D. It consists of cash that allows the company to conduct clinical trials. How has this research budget changed? The chart below shows this story.
ARTL - Share of the company's book capitalization Artelo Biosciences within the market segment - Narco farm
Artelo Biosciences develops cannabinoid-based drugs. Its scientific activities require a resource base: a laboratory for working with these specific molecules and managing clinical trials. The chart shows the company's share of the physical R&D infrastructure required for this pharmaceutical industry.
Market segment balance sheet capitalization - Narco farm
Artelo Biosciences is a biopharmaceutical company. Pharmaceuticals, as the graph shows, are both knowledge- and capital-intensive. Artelo focuses on drug development, and its capital is its intellectual property and R&D infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Artelo Biosciences' assets are not plantations, but a portfolio of intellectual property and capital for developing cannabinoid-based drugs for the treatment of cancer and post-traumatic stress disorder. These assets reflect its scientific and financial potential in this complex field.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company working with cannabinoids. Its market capitalization is a speculative estimate of its chances of developing approved drugs based on these controversial but potentially effective compounds.
Market to book capitalization ratio in a market segment - Narco farm
Artelo Biosciences is a company developing cannabinoid-based drugs. Its valuation on this chart reflects both the scientific potential of its developments, the speculative interest in the cannabis sector as a whole, and regulatory risks.
Market to book capitalization ratio for the market as a whole
Artelo Biosciences is exploring the potential of cannabinoids for the development of new drugs. This is a high-risk sector, where market value depends entirely on research results and regulatory changes. This chart illustrates investor appetite for speculative but potentially breakthrough pharmaceutical trends.
Debts of the company, segment and market as a whole
ARTL - Company debts Artelo Biosciences
Artelo, a biopharmaceutical company focused on cannabinoid therapeutics, funds its clinical programs through raised capital. This schedule reflects the financial needs and risks associated with developing drugs based on regulated substances, which require complex clinical and regulatory procedures.
Market segment debts - Narco farm
Artelo Biosciences is a clinical-stage biopharmaceutical company focused on developing drugs targeting the endocannabinoid system for the treatment of cancer, anxiety, and other diseases. This chart shows how the company is funding its research in this innovative, yet regulatory-challenging, field.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company working with the cannabinoid system to develop new drugs. Research in this area requires significant investment and is fraught with regulatory risks. This chart shows how the company uses debt to finance its clinical programs on the path to potential approval.
Market segment debt to market segment book capitalization - Narco farm
Artelo Biosciences is a biopharmaceutical company working with the cannabinoid system to develop new drugs. This is a promising, but still relatively new, field. This chart shows how the company is funding its unique research. It compares its debt to the market capitalization of the entire biotech sector, reflecting its financial risks.
Debt to book value of all companies in the market
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs. This is a promising, yet still new and regulatoryly complex field. How heavily does the company rely on debt for its research? This chart of total market debt helps assess the risks associated with financing in this niche industry.
P/E of the company, segment and market as a whole
P/E - Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. This chart shows how investors value the company at the intersection of biotech and the cannabis industry. The valuation depends on clinical trial results and the regulatory environment.
P/E of the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based therapeutics for the treatment of cancer, pain, and other diseases. This chart illustrates the average valuation in the pharmaceutical sector, but takes into account the specifics and regulatory risks associated with cannabis-based drug development.
P/E of the market as a whole
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer, pain, and other ailments. This chart reflects overall investor interest in the cannabis sector. It helps us understand whether ARTL's valuation reflects speculative interest in medical marijuana or is supported by real clinical data.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. Its future depends on the results of clinical trials and the regulatory environment. This chart shows how investors assess the scientific potential and therapeutic value of cannabinoid medicine.
%20P%2FE%20Artelo%20Biosciences&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Artelo-Biosciences&v=1772618634136 "Chart of the company's future (projected) P/E Artelo Biosciences")
Future (projected) P/E of the market segment - Narco farm
Artelo Biosciences focuses on developing drugs that target the endocannabinoid system to treat cancer and other diseases. The chart compares Artelo's future profitability expectations with those of the industry. It helps understand the market's confidence in the therapeutic potential of cannabinoids and the company's scientific developments.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772618634158 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. This sector combines biotech risks with regulatory uncertainty. This chart of overall risk appetite shows how willing investors are to invest in medical cannabis as a serious pharmaceutical industry.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772618634221 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Artelo Biosciences
Artelo Biosciences is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. Its financial metrics include R&D expenses. This chart shows investments in scientific research into the therapeutic potential of cannabis.
Profit of companies in the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer, anorexia, and other disorders. The company explores the therapeutic potential of the endocannabinoid system. This chart shows the overall profitability of the addiction treatment and related research sector, where the scientific approach to cannabinoids is opening new horizons.
Overall market profit
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs. Its success depends on the results of clinical trials and changes in cannabis regulation. This sector has its own unique growth drivers, unrelated to the general economic cycles reflected in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company focused on developing cannabinoid-based drugs for the treatment of cancer and other diseases. Future profits depend on the success of clinical trials and the regulatory environment for these drugs. This chart shows how analysts assess the scientific and commercial potential of its developments.
%20profit%20of%20the%20company%20Artelo%20Biosciences&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Artelo-Biosciences&v=1772618634520 "Graph of future (projected) profit of the company Artelo Biosciences")
Future (predicted) profit of companies in the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company exploring the potential of the cannabinoid system for the treatment of cancer, inflammatory diseases, and eating disorders. Its future depends on the results of clinical trials. This chart shows revenue projections for the pharmaceutical sector, providing context for evaluating Artelo's scientific approach.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772618634527 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Artelo Biosciences is a biopharmaceutical company working with the cannabinoid system to develop drugs. Its success depends on clinical trials and the regulatory environment. This revenue expectation schedule impacts the availability of venture capital to fund research in such an innovative but risky field.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772618634586 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company working with the cannabinoid system to develop new drugs. Its clinical-stage revenue is minimal. This chart shows how investors view its research and the commercialization potential of cannabinoid-based drugs.
P/S market segment - Narco farm
Artelo Biosciences is a clinical-stage biopharmaceutical company developing cannabinoid-based therapies for the treatment of cancer and related conditions, such as anorexia. The company is exploring the therapeutic potential of the endocannabinoid system. This chart reflects the average revenue estimate for the sector, which helps evaluate Artelo's scientific developments.
P/S of the market as a whole
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. This chart shows that the valuation of such companies reflects both the scientific potential and the regulatory risks associated with cannabis, making their comparison to the market average particularly interesting.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. Estimating future revenue is crucial for the company. It reflects investor expectations for the success of its drugs in clinical trials and for the changing regulatory environment regarding the therapeutic use of cannabinoids, which will open up the market for the company.
%20P%2FS%20Artelo%20Biosciences&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Artelo-Biosciences&v=1772618634832 "The graph of the company's future (projected) P/S Artelo Biosciences")
Future (projected) P/S of the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer, anorexia, and other conditions. This chart shows how investors assess the company's future revenues relative to the pharmaceutical sector. It demonstrates the market's confidence in the therapeutic potential of cannabinoids and the scientific validity of Artelo's developments.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772618634849 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Artelo Biosciences is a biopharmaceutical company focused on the endocannabinoid system to develop new drugs. Its research could lead to the development of treatments for cancer and other diseases. This market forecast chart reflects investor interest in the therapeutic potential of cannabinoids beyond recreational use.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772618634933 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Artelo Biosciences
This chart shows the revenue of Artelo Biosciences, a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. Being in clinical trials, the company has no commercial revenue. Any revenue is likely related to licensing agreements.
Sales of companies in the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs. While in the clinical stage, it does not yet have sales revenue. Its future revenue will depend on the success of its candidates for treating cancer-related anorexia and other conditions, demonstrating its focus on the therapeutic potential of cannabis.
Overall market sales
Artelo Biosciences is a biopharmaceutical company exploring the potential of cannabinoids to treat cancer and other diseases. Its success depends on the results of clinical trials and changes in the regulatory environment. This general economic graph does not reflect the dynamics of the innovation sector, where scientific discoveries and regulatory decisions play a key role.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based treatments for cancer, anorexia, and other conditions. Future revenue depends on the success of clinical trials and the regulatory landscape. This chart shows analyst forecasts for the commercial potential of its cannabinoid therapeutic portfolio.
%20sales%20of%20the%20company%20Artelo%20Biosciences&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Artelo-Biosciences&v=1772618635221 "Schedule of future (projected) sales of the company Artelo Biosciences")
Future (projected) sales of companies in the market segment - Narco farm
Artelo Biosciences is developing cannabinoid-based drugs for the treatment of cancer and other diseases. This chart shows the outlook for the biotech sector. Is the therapeutic cannabinoid market expected to grow as clinical trials progress and approvals are obtained? This reflects the potential of this area.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772618635300 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
Artelo Biosciences is a biopharmaceutical company developing drugs targeting the endocannabinoid system. Its success depends on clinical trial results and regulatory approval. The general economic cycles reflected in this chart are not directly related to the scientific and clinical processes that are the primary drivers of Artelo's value.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772618635360 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. This chart shows its financial trajectory during clinical trials. Profitability depends on successful research results and regulatory approval of drugs that harness the therapeutic potential of the endocannabinoid system.
Market segment marginality - Narco farm
Artelo Biosciences, Inc. is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. This chart reflects its financial performance at the R&D stage, where profitability is a future goal dependent on success in clinical trials and navigating the complex regulatory environment for cannabinoid drugs.
Market marginality as a whole
Artelo Biosciences, a cannabinoid pharmaceutical company, aims to develop drugs based on cannabis compounds. The company's success depends on regulatory changes and research results. This total return chart reflects investor risk appetite in the relatively new and speculative field of biotechnology.
Employees in the company, segment and market as a whole
Number of employees in the company Artelo Biosciences
Artelo Biosciences is a biotech company developing drugs targeting the endocannabinoid system for the treatment of cancer and other diseases. Its small team manages a portfolio of research programs. This chart shows how the company focuses its resources on advancing its candidates through early-stage clinical trials.
Share of the company's employees Artelo Biosciences within the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. Its activities are focused on research and clinical trials. This graph shows the company's market share, reflecting the scale of its R&D program in this specific area of pharmaceuticals.
Number of employees in the market segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs for the treatment of cancer and other diseases. This chart shows its presence in the addiction pharmaceuticals sector. Artelo strives to scientifically validate the therapeutic potential of cannabinoids by creating drugs with precise dosing and mechanism of action.
Number of employees in the market as a whole
Artelo Biosciences is a biopharmaceutical company exploring the therapeutic potential of cannabinoids. Its development depends on scientific discoveries and regulatory changes. Given the overall dynamics in this chart, Artelo exemplifies a company at the intersection of science and emerging industry, where job creation is driven by research progress.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Artelo Biosciences (ARTL)
Artelo Biosciences is a biotech company working with cannabinoids to develop new drugs. They are an R&D company in a hot but challenging sector. This chart shows how the market values their intellectual property. It reflects the market value per employee, which is a measure of the value of their R&D programs.
%20of%20the%20company%20Artelo%20Biosciences%20(ARTL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Artelo-Biosciences-ARTL&v=1772618635990 "Chart of market capitalization per employee (in thousands of dollars) of the company Artelo Biosciences (ARTL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Artelo Biosciences (ARTL) develops cannabinoid-based therapeutics for the treatment of cancer and other diseases. In this specific pharmaceutical sector, this metric reflects the potential of a drug portfolio. A high value may indicate unique developments that have the potential to be first-in-class and capture a significant market niche.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772618636027 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs. Its market capitalization reflects the potential of its developments in this new and promising area of medicine. The high valuation per employee in this chart reflects investors' confidence in the company's scientific team's ability to create a marketable product.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772618636059 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Artelo Biosciences (ARTL)
Artelo Biosciences is a clinical-stage biotech company working on drugs targeting the endocannabinoid system (related to cannabis). This chart reflects the R&D workload. A negative figure (loss per employee) is normal and reflects the amount of capital invested in each scientist to conduct trials.
%20Chart%20Artelo%20Biosciences%20(ARTL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Artelo-Biosciences-ARTL&v=1772618636129 "Company Profit Per Employee (in thousands of dollars) Chart Artelo Biosciences (ARTL)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Artelo Biosciences develops cannabinoid-based drugs for the treatment of cancer and other diseases. In this innovative pharmaceutical niche, productivity per employee reflects scientific potential and commercialization potential. This graph demonstrates the value each team member generates, which is important for comparison with other companies in the biopharmaceutical sector.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772618636228 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Artelo Biosciences is a biotech company working in the promising but complex field of cannabinoid therapeutics. They are developing drugs for the treatment of cancer and anxiety. This is an R&D business. This chart, reflecting average market profitability, demonstrates how the biotech model, with its small workforce and high stakes, differs from the rest of the economy.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772618636283 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Artelo Biosciences (ARTL)
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs. During the research phase, revenue per employee is typically nonexistent. The graph is important as an indicator of the future: if successful, a single approved drug could generate significant revenue, leading to explosive growth.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Artelo-Biosciences-ARTL&v=1772618636377 "Sales chart per company employee Artelo Biosciences (ARTL)")
Sales per employee in the market segment - Narco farm
Artelo Biosciences is a clinical-stage biotech company developing cannabinoid-based (cannabis-related) drugs for the treatment of oncology (cancer-related anorexia) and other diseases. They have no commercial revenue. This chart, showing the average revenue in the sector, serves as a barometer for ARTL's R&D staffing costs.
Sales per employee for the market as a whole
Artelo Biosciences is a biotech company focused on developing cannabinoid-based drugs for the treatment of cancer and other diseases. Their core business is R&D, which reflects their clinical stage: the company is investing in research and does not yet have a commercial product on the market.
Short shares by company, segment and market as a whole
Shares shorted by company Artelo Biosciences (ARTL)
Artelo (ARTL) is a biotech company operating in the cannabinoid sector. It develops cannabis-based medications for the treatment of various ailments. This chart shows the number of short positions. Bears may doubt both the effectiveness of these drugs and their ability to pass the FDA's rigorous regulatory review.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Artelo-Biosciences-ARTL&v=1772618636605 "Short Shares Chart for the Company Artelo Biosciences (ARTL)")
Shares shorted by market segment - Narco farm
Artelo Biosciences (ARTL) is a biotech company specializing in the development of drugs that modulate the endocannabinoid system for the treatment of cancer and anxiety disorders. This chart aggregates short positions across the biotech sector. It reflects investor skepticism about cannabinoid drugs and the risks of clinical trials.
Shares shorted by the overall market
Artelo (ARTL) operates in the speculative cannabinoid-related biotech sector. When this general fear indicator rises, investors flee risk. They sell off the "double risk": both unprofitable biotechs and the cannabis sector.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Artelo Biosciences (ARTL)
Artelo Biosciences (ARTL) is a biotech company working with cannabinoids to treat cancer and anxiety disorders. This is a speculative area. This oscillator measures the strength of speculative moves. It shows when the stock is "overheated" (above 70) on legalization news or data, or "oversold" (below 30) due to delays.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Artelo-Biosciences-ARTL&v=1772618636827 "RSI 14 indicator chart for the company's stock Artelo Biosciences (ARTL)")
RSI 14 Market Segment - Narco farm
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs (including synthetic ones) for the treatment of cancer and rare diseases. This chart shows the overall "temperature" of the entire speculative "pharma-cannabis" sector. It clearly demonstrates when the entire industry is "overheated" by expectations or "oversold" by news.
RSI 14 for the overall market
Artelo Biosciences (ARTL) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ARTL (Artelo Biosciences)
Artelo Biosciences is a biopharmaceutical company developing cannabinoid-based drugs (including synthetic ones) for the treatment of cancer-related cachexia (weight loss) and anxiety disorders. This chart shows the speculative average price target from analysts, which is almost entirely dependent on their confidence in the success of these clinical trials.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ARTL-Artelo-Biosciences&v=1772618636986 "A chart showing analyst consensus forecasts for the expected stock price. ARTL (Artelo Biosciences)")
The difference between the consensus estimate and the actual stock price ARTL (Artelo Biosciences)
Artelo Biosciences is a biotech company that uses the body's cannabinoid system to develop treatments for cancer and anorexia. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in the scientific potential of this "cannabis R&D" company.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ARTL-Artelo-Biosciences&v=1772618637030 "A chart showing the difference between the consensus forecast and the actual stock price. ARTL (Artelo Biosciences)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Artelo (ARTL) is a biotech company developing drugs targeting the body's cannabinoid system (CB1/CB2) for the treatment of cancer, pain, and anorexia. This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe in the medical potential of cannabinoid science.
Analysts' consensus forecast for the overall market share price
Artelo Biosciences is a biotech company developing cannabinoid-based drugs for the treatment of cancer (anorexia) and central nervous system disorders. This chart reflects the overall market "risk appetite." For Artelo, which operates at the intersection of biotech and the speculative cannabis sector, overall market optimism (risk appetite) is critical for funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Artelo Biosciences
Artelo Biosciences is a biotech R&D company trying to tame cannabis. They are developing new, proprietary molecules that modulate the endocannabinoid system (CB1/CB2 receptors) to treat cancer and anxiety. This chart is a barometer of cannabis science. It reflects their (highly risky) R&D progress and their chances of FDA approval.
AKIMA Market Segment Index - Narco farm
Artelo Biosciences (ARTL) is a biopharmaceutical company taking a scientific approach to cannabinoids. They develop synthetic drugs targeting the endocannabinoid system to treat anorexia (related to cancer) and other disorders. This chart shows the average index for the segment, helping to assess how this medical cannabis strategy compares to the average market.
The AKIM Index for the overall market
Artelo Biosciences is a biopharmaceutical company developing drugs that target the endocannabinoid system for the treatment of cancer and pain. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this scientific platform compares to overall economic trends.
